2025 ASCO Annual Meeting Highlight: AGITG dynamic-III Trial
· Meetings
Dr. Bishal Gyamali discusses results from the AGITG dynamic-III trial presented during the 2025 ASCO Annual Meeting. This was a randomized trial studying ctDNA-guided adjuvant chemotherapy escalation in stage III colon cancer.
Link to ecancer discussion
Link to ASCO abstract
Get notified of new trials and updates
One email when something new is posted: a new clinical trial, meeting highlights, or educational material. No spam, unsubscribe any time.
Prefer a reader? Use the RSS feed.